Summit Therapeutics Inc. Foreign Currency Transaction Gain (Loss), Unrealized
Summit Therapeutics Inc. (SMMT) reported Foreign Currency Transaction Gain (Loss), Unrealized of -$220.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2026-07-23
- Summit Therapeutics Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2026-06-30 was -$30.00K, a 112.55% decline year-over-year.
- Summit Therapeutics Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2026-03-31 was -$190.00K, a 184.82% decline year-over-year.
- Summit Therapeutics Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-12-31 was -$94.00K, a 154.97% decline year-over-year.
- Summit Therapeutics Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-09-30 was -$49.00K.
- Summit Therapeutics Inc. foreign currency transaction gain (loss), unrealized for fiscal 2025 was $320.00K.
- Summit Therapeutics Inc. foreign currency transaction gain (loss), unrealized for fiscal 2024 was -$229.00K, a 128.20% decline from fiscal 2023.
- Summit Therapeutics Inc. foreign currency transaction gain (loss), unrealized for fiscal 2023 was $812.00K.
- Summit Therapeutics Inc. foreign currency transaction gain (loss), unrealized for fiscal 2022 was -$2.62M.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month as first filed | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 11 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | -$220.00K 10-Q · filed 2026-07-23 | -$314.00K derived: sum of 3 quarters · filed 2026-07-23 | -$363.00K derived: sum of 4 quarters · filed 2026-07-23 | |||
| 2026-03-31 | -$190.00K 10-Q · filed 2026-04-30 | -$284.00K derived: sum of 2 quarters · filed 2026-04-30 | -$333.00K derived: sum of 3 quarters · filed 2026-04-30 | -$94.00K derived: sum of 4 quarters · filed 2026-07-23 | |||
| 2025-12-31 | -$94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$143.00K derived: sum of 2 quarters · filed 2026-02-23 | $96.00K derived: sum of 3 quarters · filed 2026-07-23 | $320.00K 10-K · filed 2026-02-23 | |||
| 2025-09-30 | -$49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-20 | $190.00K derived: sum of 2 quarters · filed 2026-07-23 | $414.00K 10-Q · filed 2025-10-20 | $585.00K derived: sum of 4 quarters · filed 2026-07-23 | |||
| 2025-06-30 | $239.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $463.00K 10-Q · filed 2026-07-23 | $634.00K derived: sum of 3 quarters · filed 2026-07-23 | $119.00K derived: sum of 4 quarters · filed 2026-07-23 | |||
| 2025-03-31 | $224.00K 10-Q · filed 2026-04-30 | $395.00K derived: sum of 2 quarters · filed 2026-04-30 | -$120.00K derived: sum of 3 quarters · filed 2026-04-30 | $4.00K derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | $171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$344.00K derived: sum of 2 quarters · filed 2026-02-23 | -$220.00K derived: sum of 3 quarters · filed 2026-02-23 | -$229.00K 10-K · filed 2026-02-23 | |||
| 2024-09-30 | -$515.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-20 | -$391.00K derived: sum of 2 quarters · filed 2025-10-20 | -$400.00K 10-Q · filed 2025-10-20 | $42.00K derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-06-30 | $124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $115.00K 10-Q · filed 2025-08-11 | $557.00K derived: sum of 3 quarters · filed 2026-02-23 | $63.00K derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-03-31 | -$9.00K 10-Q · filed 2025-05-01 | $433.00K derived: sum of 2 quarters · filed 2026-02-23 | -$61.00K derived: sum of 3 quarters · filed 2026-02-23 | $333.00K derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2023-12-31 | $442.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$52.00K derived: sum of 2 quarters · filed 2026-02-23 | $342.00K derived: sum of 3 quarters · filed 2026-02-23 | $812.00K 10-K · filed 2026-02-23 | |||
| 2023-09-30 | -$494.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$100.00K derived: sum of 2 quarters · filed 2024-10-30 | $370.00K 10-Q · filed 2024-10-30 | $2.02M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2023-06-30 | $394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $864.00K 10-Q · filed 2024-08-06 | $2.52M derived: sum of 3 quarters · filed 2025-02-24 | $614.00K derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2023-03-31 | $470.00K 10-Q · filed 2024-05-01 | $2.13M derived: sum of 2 quarters · filed 2025-02-24 | $220.00K derived: sum of 3 quarters · filed 2025-02-24 | -$1.11M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2022-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | -$250.00K derived: sum of 2 quarters · filed 2025-02-24 | -$1.58M derived: sum of 3 quarters · filed 2025-02-24 | -$2.62M 10-K · filed 2025-02-24 | -$2.61M 10-K · filed 2023-03-09 | ||
| 2022-09-30 | -$1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$3.23M derived: sum of 2 quarters · filed 2023-11-07 | -$4.27M 10-Q · filed 2023-11-07 | -$5.24M derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2022-06-30 | -$1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$2.37M 10-Q · filed 2023-08-09 | -$3.34M derived: sum of 3 quarters · filed 2023-08-09 | -$4.19M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | -$1.04M 10-Q · filed 2023-05-11 | -$2.01M derived: sum of 2 quarters · filed 2023-05-11 | -$2.86M derived: sum of 3 quarters · filed 2023-05-11 | -$3.08M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$972.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$1.82M derived: sum of 2 quarters · filed 2023-03-09 | -$2.04M derived: sum of 3 quarters · filed 2023-03-09 | -$326.00K 10-K · filed 2023-03-09 | |||
| 2021-09-30 | -$849.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.07M derived: sum of 2 quarters · filed 2022-11-09 | $646.00K 10-Q · filed 2022-11-09 | $884.00K derived: sum of 4 quarters · filed 2022-12-21 | |||
| 2021-06-30 | -$224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.50M 10-Q · filed 2022-08-11 | $1.73M derived: sum of 3 quarters · filed 2022-12-21 | $1.48M derived: sum of 4 quarters · filed 2022-12-21 | |||
| 2021-03-31 | $1.72M 10-Q · filed 2022-05-11 | $1.96M derived: sum of 2 quarters · filed 2022-12-21 | $1.71M derived: sum of 3 quarters · filed 2022-12-21 | $2.07M derived: sum of 4 quarters · filed 2022-12-21 | |||
| 2020-12-31 | $238.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-12-21 | -$14.00K derived: sum of 2 quarters · filed 2022-12-21 | $353.00K derived: sum of 3 quarters · filed 2022-12-21 | $278.00K 10-K/A · filed 2022-12-21 | |||
| 2020-09-30 | -$252.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $115.00K derived: sum of 2 quarters · filed 2021-11-15 | $40.00K 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $367.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $292.00K 10-Q · filed 2021-08-12 | $294.00K 8-K · filed 2020-09-29 | ||||
| 2020-03-31 | -$75.00K 10-Q · filed 2021-05-17 | ||||||
| 2019-12-31 | -$423.00K 10-K · filed 2021-03-31 | ||||||
| 2019-09-30 | -$464.00K derived: 10-Q 9 month − 8-K 6 month · filed 2020-11-16 | -$342.00K 10-Q · filed 2020-11-16 | |||||
| 2019-06-30 | $122.00K 8-K · filed 2020-09-29 | ||||||
| 2019-01-31 | $0.00 10-K · filed 2021-03-31 | ||||||
| 2018-01-31 | $0.00 8-K · filed 2020-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |